Post by Andy Peacher Tel 07827731060 on Mar 20, 2012 14:52:35 GMT
ADDERALL:
Adderall is a central nervous system stimulant. It affects chemicals in the brain and nerves that contribute to hyperactivity and impulse control.
Adderall is used to treat narcolepsy and attention deficit hyperactivity disorder (ADHD).
Adderall may also be used for other purposes not listed in this medication guide.
Adderall has been linked to violent behavior when, in 2000, a North Dakota judge acquitted 26-year-old Ray Ehlis of murdering his 5-week-old daughter after two independent psychiatrists testified he was suffering a severe psychosis induced by Adderall.
June 2004: The FDA ordered that the packaging for Adderall include a warning about sudden cardiovascular deaths, especially in children with underlying heart disease.
February 9, 2005: Health Canada, the Canadian counterpart of the FDA, suspended marketing of Adderall XR (Extended Release, given once a day) due to reports of 20 sudden unexplained deaths (14 in children) and 12 strokes (2 in children) in patients taking Adderall or Adderall XR. However, in August 2005, Health Canada agreed to reinstate the marketing authorization with a number of revisions to the labeling. The labeling was revised to include warnings against the use of Adderall XR18 in patients with structural heart abnormalities and advised about the dangers of misusing amphetamines.
April 21, 2005: Partnership for a Drug-Free America, released its findings of a study that determined that 10% of teens (2.3 million) had abused the stimulants Adderall and Ritalin.
Adderall is a central nervous system stimulant. It affects chemicals in the brain and nerves that contribute to hyperactivity and impulse control.
Adderall is used to treat narcolepsy and attention deficit hyperactivity disorder (ADHD).
Adderall may also be used for other purposes not listed in this medication guide.
Adderall has been linked to violent behavior when, in 2000, a North Dakota judge acquitted 26-year-old Ray Ehlis of murdering his 5-week-old daughter after two independent psychiatrists testified he was suffering a severe psychosis induced by Adderall.
June 2004: The FDA ordered that the packaging for Adderall include a warning about sudden cardiovascular deaths, especially in children with underlying heart disease.
February 9, 2005: Health Canada, the Canadian counterpart of the FDA, suspended marketing of Adderall XR (Extended Release, given once a day) due to reports of 20 sudden unexplained deaths (14 in children) and 12 strokes (2 in children) in patients taking Adderall or Adderall XR. However, in August 2005, Health Canada agreed to reinstate the marketing authorization with a number of revisions to the labeling. The labeling was revised to include warnings against the use of Adderall XR18 in patients with structural heart abnormalities and advised about the dangers of misusing amphetamines.
April 21, 2005: Partnership for a Drug-Free America, released its findings of a study that determined that 10% of teens (2.3 million) had abused the stimulants Adderall and Ritalin.